Company: GEHC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001932393-25-000049
Chunk: 132

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 2
Chunk 132
---
 Canada (“USCAN”)    $2,340$2,2434%$4,577$4,3366%Europe, the Middle East, and Africa (“EMEA”)    1,2681,2065%2,4422,3803%China region    563583(3)%1,1561,180(2)%Rest of World    8368074%1,6091,5921%Total revenues    $5,007$4,8393%$9,784$9,4893%

For the three months ended June 30, 2025

Total revenues were $5,007 million, growing 3% as reported and 2% organically*. The reported growth was largely driven by Sales of services increasing 7% or $111 million primarily driven by growth in new and existing customer contractual agreements.

____________________

*Non-GAAP Financial Measure

32

Table of Contents             

The segment revenues were as follows:

•Imaging segment revenues were $2,204 million, growing 2% or $33 million, with growth in the EMEA and USCAN regions, largely offset by continued pressure in the China market;

•AVS segment revenues were $1,289 million, growing 3% or $41 million, driven by continued strength in the U.S. market;

•PCS segment revenues were $778 million, growing 1% or $6 million, driven by growth in Monitoring Solutions, largely offset by a challenging year-over-year comparison in Life Support Solutions; and

•PDx segment revenues were $729 million, growing 14% or $90 million as reported, driven by the acquisition of Nihon Medi-Physics Co., Ltd. (“NMP”) and an increase in Organic revenue*. Organic revenue* grew 5% driven by continued growth in price and volume.

The regional revenues were as follows:

•USCAN revenues were $2,340 million, growing 4% or $97 million with growth across all segment revenues, led by strong growth in AVS and PDx revenues;

•EMEA revenues were $1,268 million, growing 5% or $61 million, with growth in Imaging revenues as well as favorable foreign currency impacts;

•China region revenues were $563 million, decreasing 3% or $20 million due to a decrease in Imaging revenues, partially offset by growth in PDx and AVS revenues; and

•Rest of World revenues were $836 million,